Title : Gastrointestinal stromal tumours.

Pub. Date : 2021 Mar 18

PMID : 33737510






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Patients with GIST with KIT or PDGFRA mutations sensitive to the tyrosine kinase inhibitor (TKI) imatinib that are at high risk of relapse have improved survival with adjuvant imatinib treatment. Imatinib Mesylate KIT proto-oncogene, receptor tyrosine kinase Homo sapiens
2 Patients with GIST with KIT or PDGFRA mutations sensitive to the tyrosine kinase inhibitor (TKI) imatinib that are at high risk of relapse have improved survival with adjuvant imatinib treatment. Imatinib Mesylate KIT proto-oncogene, receptor tyrosine kinase Homo sapiens